A. Lohmann

652 total citations
22 papers, 436 citations indexed

About

A. Lohmann is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Management of Technology and Innovation. According to data from OpenAlex, A. Lohmann has authored 22 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 5 papers in Molecular Biology and 5 papers in Management of Technology and Innovation. Recurrent topics in A. Lohmann's work include Neurotransmitter Receptor Influence on Behavior (8 papers), Neuroscience and Neuropharmacology Research (6 papers) and Blood transfusion and management (5 papers). A. Lohmann is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (8 papers), Neuroscience and Neuropharmacology Research (6 papers) and Blood transfusion and management (5 papers). A. Lohmann collaborates with scholars based in Germany, Bulgaria and United States. A. Lohmann's co-authors include Markus B. Funk, Brigitte Keller‐Stanislawski, M. Heiden, Jacky Emmerton, Jean De Vry, R. de Beun, Renate Schneider, K.‐M. Hanschmann, A. Hunfeld and Juan D. Delius and has published in prestigious journals such as Psychopharmacology, European Journal of Pharmacology and Electroencephalography and Clinical Neurophysiology.

In The Last Decade

A. Lohmann

22 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Lohmann Germany 11 127 102 80 75 74 22 436
Thomas Esmonde United Kingdom 15 6 0.0× 211 2.1× 14 0.2× 523 7.0× 18 0.2× 22 933
Sarah Khan Saudi Arabia 11 5 0.0× 10 0.1× 19 0.2× 89 1.2× 22 482
Susan Brief United States 6 15 0.1× 23 0.2× 13 0.2× 73 1.0× 7 419
Mária Székely United Kingdom 10 11 0.1× 14 0.1× 10 0.1× 220 2.9× 31 430
Ulla Sollenberg Sweden 12 6 0.0× 381 3.7× 22 0.3× 349 4.7× 12 685
Ariela Gordon‐Shaag Israel 19 39 0.3× 147 1.4× 3 0.0× 241 3.2× 40 1.6k
Ian Atkinson Canada 10 5 0.0× 13 0.1× 31 0.4× 110 1.5× 17 416
Peter Dimitrov Australia 20 73 0.6× 79 0.8× 6 0.1× 312 4.2× 1 0.0× 40 1.1k
Tiago M. Alfaro Portugal 11 5 0.0× 168 1.6× 3 0.0× 133 1.8× 1 0.0× 30 565
Ahmed Deldar United States 12 1 0.0× 15 0.1× 91 1.1× 36 0.5× 22 554

Countries citing papers authored by A. Lohmann

Since Specialization
Citations

This map shows the geographic impact of A. Lohmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Lohmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Lohmann more than expected).

Fields of papers citing papers by A. Lohmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Lohmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Lohmann. The network helps show where A. Lohmann may publish in the future.

Co-authorship network of co-authors of A. Lohmann

This figure shows the co-authorship network connecting the top 25 collaborators of A. Lohmann. A scholar is included among the top collaborators of A. Lohmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Lohmann. A. Lohmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Funk, Markus B., M. Heiden, Peter Volkers, A. Lohmann, & Brigitte Keller‐Stanislawski. (2015). Evaluation of Risk Minimisation Measures for Blood Components - Based on Reporting Rates of Transfusion-Transmitted Reactions (1997-2013). Transfusion Medicine and Hemotherapy. 42(4). 240–246. 17 indexed citations
3.
Funk, Markus B., et al.. (2015). Recht – Hämovigilanz. 5(2). 102–107. 1 indexed citations
4.
Funk, Markus B., et al.. (2013). Thromboembolic events associated with immunoglobulin treatment. Vox Sanguinis. 105(1). 54–64. 45 indexed citations
5.
Funk, Markus B., et al.. (2011). Transfusion-Transmitted Bacterial Infections – Haemovigilance Data of German Blood Establishments (1997–2010). Transfusion Medicine and Hemotherapy. 38(4). 266–271. 36 indexed citations
6.
Funk, Markus B., et al.. (2011). Benefit of transfusion‐related acute lung injury risk‐minimization measures – German haemovigilance data (2006–2010). Vox Sanguinis. 102(4). 317–323. 45 indexed citations
7.
Funk, Markus B., et al.. (2010). Bewertung der Maßnahmen zur Reduktion schwerwiegender Transfusionsreaktionen (Hämovigilanzdaten von 1997 bis 2008). Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 53(4). 347–356. 8 indexed citations
8.
Keller‐Stanislawski, Brigitte, et al.. (2009). The German Haemovigilance System–reports of serious adverse transfusion reactions between 1997 and 2007. Transfusion Medicine. 19(6). 340–349. 64 indexed citations
9.
Vry, Jochen De, et al.. (1997). P.5.026 Effects of the calcium channel blocker, nimodipine, on the discriminative and reinforcing stimulus properties of alcohol. European Neuropsychopharmacology. 7. S260–S260. 3 indexed citations
10.
Emmerton, Jacky, et al.. (1997). Pigeons’ serial ordering of numerosity with visual arrays. Animal Learning & Behavior. 25(2). 234–244. 76 indexed citations
11.
Beun, R. de, et al.. (1996). Effects of nimodipine and other calcium channel antagonists in alcohol-preferring AA rats. Alcohol. 13(3). 263–271. 46 indexed citations
12.
Beun, R. de, et al.. (1996). The calcium channel agonist BAY k 8644 reduces ethanol intake and preference in alcohol-preferring AA rats. Psychopharmacology. 127(4). 302–310. 14 indexed citations
13.
Beun, R. de, A. Lohmann, Renate Schneider, & Jean De Vry. (1996). Comparison of the stimulus properties of ethanol and the Ca2+ channel antagonist nimodipine in rats. European Journal of Pharmacology. 306(1-3). 5–13. 22 indexed citations
14.
Beun, R. de, A. Lohmann, & Jean De Vry. (1996). Conditioned taste aversion and place preference induced by the calcium channel antagonist nimodipine in rats. Pharmacology Biochemistry and Behavior. 54(4). 657–663. 11 indexed citations
15.
Beun, R. de, et al.. (1996). Stimulus properties of the L???type calcium channel agonist BAY k 8644 in rats. Behavioural Pharmacology. 7(8). 346–354. 7 indexed citations
16.
Beun, R. de, et al.. (1996). The calcium channel agonist BAY k 8644 reduces ethanol intake and preference in alcohol-preferring AA rats. Psychopharmacology. 127(1-2). 302–310. 5 indexed citations
17.
Beun, R. de, et al.. (1995). P-10-20 Effects of putative anticraving drugs in alcohol preferring AA rats. European Neuropsychopharmacology. 5(3). 399–399. 1 indexed citations
18.
Lohmann, A., et al.. (1988). Discrimination of shape reflections and shape orientations by Columba livia... Journal of comparative psychology. 102(1). 3–13. 19 indexed citations
19.
Lohmann, A., et al.. (1988). Discrimination of shape reflections and shape orientations by Columba livia.. Journal of comparative psychology. 102(1). 3–13. 3 indexed citations
20.
Schulte, F. J. & A. Lohmann. (1962). The electroencephalogram and electromyogram in experimental hypocalcemia. Electroencephalography and Clinical Neurophysiology. 14(6). 915–920. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026